Tag: NHS reform
Latest articles
GlaxoSmithKline’s Zejula (niraparib) approved for treatment of ovarian cancer
The European Commission has approved GlaxoSmithKline's (GSK) Zejula (niraparib), an oral, once-daily poly (ADP-ribose) polymerase (PARP) inhibitor, as first-line monotherapy maintenance treatment for adult...
Ten top tips for pharma and healthcare to avoid data breaches
Every organisation is a software organisation but for healthcare providers and pharmaceutical organisations, the stakes are high when it comes to data breaches. In...
TherapeutAix expands R&D network to Alderley Analytical and Peak Proteins
Life sciences consultancy, TherapeutAix, has added contract research organisations (CROs), Alderley Analytical and Peak Proteins to its global R&D network. The partnership will form...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Pfizer suffers huge data breach on unsecured cloud storage
Global pharmaceutical giant Pfizer Inc. has suffered a huge data breach, with patient information found exposed on unsecured cloud storage. The exposed data was...
How sales professionals can engage with their customers during COVID-19
The impact of COVID-19 has affected how sales professionals engage with customers. What does the way forward look like? Richard Gray and Stephen Dempster...
Kate Bingham appointed Chair of UK Vaccine Taskforce
Kate Bingham has been appointed Chair of the UK’s Vaccine Taskforce – the group set up by the Government’s Chief Scientific Adviser, Deputy Chief...
GlaxoSmithKline’s Zejula (niraparib) approved for treatment of ovarian cancer
The European Commission has approved GlaxoSmithKline's (GSK) Zejula (niraparib), an oral, once-daily poly (ADP-ribose) polymerase (PARP) inhibitor, as first-line monotherapy maintenance treatment for adult...